Working… Menu

RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors (PIRATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04525014
Recruitment Status : Not yet recruiting
First Posted : August 24, 2020
Last Update Posted : July 21, 2021
Texas Children's Cancer Center
Information provided by (Responsible Party):
EpicentRx, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : September 2023
Estimated Study Completion Date : December 2023